Unfavorable effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors on the skeletal system of nondiabetic rats

Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a new class of antidiabetic drugs, acting by inhibiting the reabsorption of glucose in the kidneys. They turned out to improve cardiovascular and renal outcomes not only in patients with type 2 diabetes but also in nondiabetic patients. At presen...

Full description

Bibliographic Details
Main Authors: Piotr Londzin, Agata Brudnowska, Katarzyna Kurkowska, Katarzyna Wilk, Karolina Olszewska, Łukasz Ziembiński, Aleksandra Janas, Urszula Cegieła, Joanna Folwarczna
Format: Article
Language:English
Published: Elsevier 2022-11-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S075333222201068X
_version_ 1811340786520817664
author Piotr Londzin
Agata Brudnowska
Katarzyna Kurkowska
Katarzyna Wilk
Karolina Olszewska
Łukasz Ziembiński
Aleksandra Janas
Urszula Cegieła
Joanna Folwarczna
author_facet Piotr Londzin
Agata Brudnowska
Katarzyna Kurkowska
Katarzyna Wilk
Karolina Olszewska
Łukasz Ziembiński
Aleksandra Janas
Urszula Cegieła
Joanna Folwarczna
author_sort Piotr Londzin
collection DOAJ
description Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a new class of antidiabetic drugs, acting by inhibiting the reabsorption of glucose in the kidneys. They turned out to improve cardiovascular and renal outcomes not only in patients with type 2 diabetes but also in nondiabetic patients. At present, they are more and more widely used in patients without diabetes. Since there were concerns that SGLT2 inhibitors may increase fracture risk in diabetes, the aim of the study was to examine the effect of dapagliflozin and canagliflozin on the musculoskeletal system of nondiabetic, healthy rats. The experiments were carried out on mature female rats, divided into the control rats and rats treated with dapagliflozin (1.4 mg/kg p.o.) or canagliflozin (4.2 mg/kg p.o.) for 4 weeks. Serum bone turnover markers, skeletal muscle strength and mass, bone mass, density, histomorphometric parameters and mechanical properties were determined. Administration of the drugs did not affect the skeletal muscle mass and strength. There was no effect on serum bone turnover markers, and bone mass and composition. However, administration of both drugs resulted in disorders of cancellous bone microarchitecture and worsening of bone mechanical properties. In conclusion, both SGLT2 inhibitors unfavorably affected the skeletal system of healthy rats.
first_indexed 2024-04-13T18:47:08Z
format Article
id doaj.art-4520766e8ad64cfbb14ae698db638acb
institution Directory Open Access Journal
issn 0753-3322
language English
last_indexed 2024-04-13T18:47:08Z
publishDate 2022-11-01
publisher Elsevier
record_format Article
series Biomedicine & Pharmacotherapy
spelling doaj.art-4520766e8ad64cfbb14ae698db638acb2022-12-22T02:34:33ZengElsevierBiomedicine & Pharmacotherapy0753-33222022-11-01155113679Unfavorable effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors on the skeletal system of nondiabetic ratsPiotr Londzin0Agata Brudnowska1Katarzyna Kurkowska2Katarzyna Wilk3Karolina Olszewska4Łukasz Ziembiński5Aleksandra Janas6Urszula Cegieła7Joanna Folwarczna8Department of Pharmacology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Katowice, PolandDepartment of Pharmacology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Katowice, PolandDepartment of Pharmacology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Katowice, PolandDepartment of Pharmacology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Katowice, PolandDepartment of Pharmacology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Katowice, PolandDepartment of Pharmacology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Katowice, PolandDepartment of Pharmacology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Katowice, PolandDepartment of Pharmacology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Katowice, PolandCorresponding author.; Department of Pharmacology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Katowice, PolandSodium-glucose cotransporter 2 (SGLT2) inhibitors are a new class of antidiabetic drugs, acting by inhibiting the reabsorption of glucose in the kidneys. They turned out to improve cardiovascular and renal outcomes not only in patients with type 2 diabetes but also in nondiabetic patients. At present, they are more and more widely used in patients without diabetes. Since there were concerns that SGLT2 inhibitors may increase fracture risk in diabetes, the aim of the study was to examine the effect of dapagliflozin and canagliflozin on the musculoskeletal system of nondiabetic, healthy rats. The experiments were carried out on mature female rats, divided into the control rats and rats treated with dapagliflozin (1.4 mg/kg p.o.) or canagliflozin (4.2 mg/kg p.o.) for 4 weeks. Serum bone turnover markers, skeletal muscle strength and mass, bone mass, density, histomorphometric parameters and mechanical properties were determined. Administration of the drugs did not affect the skeletal muscle mass and strength. There was no effect on serum bone turnover markers, and bone mass and composition. However, administration of both drugs resulted in disorders of cancellous bone microarchitecture and worsening of bone mechanical properties. In conclusion, both SGLT2 inhibitors unfavorably affected the skeletal system of healthy rats.http://www.sciencedirect.com/science/article/pii/S075333222201068XSGLT2 inhibitorsBoneRats
spellingShingle Piotr Londzin
Agata Brudnowska
Katarzyna Kurkowska
Katarzyna Wilk
Karolina Olszewska
Łukasz Ziembiński
Aleksandra Janas
Urszula Cegieła
Joanna Folwarczna
Unfavorable effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors on the skeletal system of nondiabetic rats
Biomedicine & Pharmacotherapy
SGLT2 inhibitors
Bone
Rats
title Unfavorable effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors on the skeletal system of nondiabetic rats
title_full Unfavorable effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors on the skeletal system of nondiabetic rats
title_fullStr Unfavorable effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors on the skeletal system of nondiabetic rats
title_full_unstemmed Unfavorable effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors on the skeletal system of nondiabetic rats
title_short Unfavorable effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors on the skeletal system of nondiabetic rats
title_sort unfavorable effects of sodium glucose cotransporter 2 sglt2 inhibitors on the skeletal system of nondiabetic rats
topic SGLT2 inhibitors
Bone
Rats
url http://www.sciencedirect.com/science/article/pii/S075333222201068X
work_keys_str_mv AT piotrlondzin unfavorableeffectsofsodiumglucosecotransporter2sglt2inhibitorsontheskeletalsystemofnondiabeticrats
AT agatabrudnowska unfavorableeffectsofsodiumglucosecotransporter2sglt2inhibitorsontheskeletalsystemofnondiabeticrats
AT katarzynakurkowska unfavorableeffectsofsodiumglucosecotransporter2sglt2inhibitorsontheskeletalsystemofnondiabeticrats
AT katarzynawilk unfavorableeffectsofsodiumglucosecotransporter2sglt2inhibitorsontheskeletalsystemofnondiabeticrats
AT karolinaolszewska unfavorableeffectsofsodiumglucosecotransporter2sglt2inhibitorsontheskeletalsystemofnondiabeticrats
AT łukaszziembinski unfavorableeffectsofsodiumglucosecotransporter2sglt2inhibitorsontheskeletalsystemofnondiabeticrats
AT aleksandrajanas unfavorableeffectsofsodiumglucosecotransporter2sglt2inhibitorsontheskeletalsystemofnondiabeticrats
AT urszulacegieła unfavorableeffectsofsodiumglucosecotransporter2sglt2inhibitorsontheskeletalsystemofnondiabeticrats
AT joannafolwarczna unfavorableeffectsofsodiumglucosecotransporter2sglt2inhibitorsontheskeletalsystemofnondiabeticrats